The success of the National Center relies on its ability to collaborate with a wide audience. Building collaborative relationships with other research centers, universities, companies, and new business ventures, demonstrates the National Center’s commitment to bringing break through treatments to market. Whether you represent a leading pharmaceutical company or a young biotech startup, the National Center is eager to hear from you.
Aimed at facilitating and expanding research activities, the National Center for Gene Therapy and Drugs based on RNA Technology activates Open Calls proposed by Spokes. Open Calls focus on acquiring new skills and technologies outside the current scope of National Center Spokes and relative affiliates.
Led by University of Modena and Reggio Emilia, Spoke 1 coordinates activities related to RNA-based technologies in Genetic Diseases.
Led by Sapienza University of Rome, Spoke 2 coordinates activities related to RNA-based technologies in Cancer.
Led by the Italian Institute of Technology (IIT), Spoke 3 coordinates activities related to RNA-based technologies in Neurodegeneration.
Led by University of Padua, Spoke 4 coordinates activities related to RNA-based technologies in Metabolic and Cardiovascular Diseases.
Led by University of Siena, Spoke 5 coordinates activities related to RNA-based technologies in Infectious and Inflammatory Diseases.
Led by University of Bari Aldo Moro, Spoke 7 coordinates Biocomputing activities related to RNA-based technologies.
Led by University of Naples Federico II, Spoke 8 coordinates activities related to Platforms for RNA/DNA Delivery.
Led by University of Milan, Spoke 9 coordinates the Competence Center on RNA Drug Pharmacology: From target to therapy: pharmacology, safety, and regulatory competence center.
Led by IRCCS Bambino Gesù Children’s Hospital in Rome (OPBG), Spoke 10 coordinates activities related to pre-clinical development, Good Manufacturing Practices (GMP) and clinical trials of Gene Therapy Medicinal Products (GTMPs).